Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCR repertoire analysis after hepatitis vaccination
NL-OMON56630Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of hepatitis b vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV) (2 cohorts), sponsored by University Medical Center Utrecht. Primary endpoint: TCR repertoire diversity of hepatitis-specific T cells. Started Apr 2025; status: recruiting.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON56630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56630.